Dr. Jon Stoessl, Director of the Pacific Parkinson’s Research Centre, played a key role in a recent Mayo Clinic-led medical breakthrough in the study of Perry’s Syndrome. The rare syndrome is caused by a genetic defect and the mechanism that's believed to be linked to the origins of various neurodegenerative disorders, such as Parkinson’s...
An important new laboratory has opened that adds to the technical infrastructure supported by the Superconducting Radio Frequency (SRF) Group at TRIUMF. The Chemical Etching Laboratory is used to 'superclean’ ultra-pure Niobium, both prior to welding during the cavity fabrication process and after the cavity is complete...
Physicians and patients around the world are increasingly anxious about the shortage of nuclear isotopes used for medical imaging in the diagnosis and treatment of cancer, brain disease and cardiac problems. The Union of Concerned Scientists issued a call to improve supplies earlier this month...
Last month on January 20, 2009, TRIUMF’s Daniel Roberge received a $10,000 cheque. No, he did not win the lottery; it was the annually awarded Dr. Carl H. Westcott Memorial Fellowship, granted to one outstanding graduate student at TRIUMF each year.
The Institute of Particle Physics (IPP) and TRIUMF are releasing new web sites this week. These sites aim to reach a broader audience of stakeholders, better serve members of the Canadian subatomic physics community and inform the general public about ongoing projects and experiments...